^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Gastroesophageal Junction Adenocarcinoma |
| Drug: | irinotecan (Topoisomerase I inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Esophageal and Esophagogastric Junction Cancers: Preferred regimens…Irinotecan.
